Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. 2006

A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.

Secretory immunoglobulin A (SIgA) plays an important role in the defence of the gastrointestinal tract. The level of faecal SIgA antibody is associated with increased neutralization and clearance of viruses. Formula-fed infants who lack the transfer of protective maternal SIgA from breast milk may benefit from strategies to support maturation of humoral immunity and endogenous production of SIgA. We aimed at studying the effects of standard, prebiotic and probiotic infant formulas on the faecal SIgA levels. At birth, infants of whom the mother had decided not to breastfeed were allocated to one of three formula groups in a randomized, double-blind fashion. Nineteen infants received standard infant formula; 19 received prebiotic formula containing a specific mixture of 0.6 g galacto-oligosaccharides (GOS)/fructo-oligosaccharides (FOS)/100 ml formula and 19 received probiotic formula containing 6.0 x 10(9) cfu Bifidobacterium animalis/100 ml formula. Faecal samples were taken on postnatal day 5, day 10, wk 4 and every 4 wk thereafter until wk 32. SIgA in faeces was determined by an enzyme-linked immunosorbent assay. During the intervention, infants fed on prebiotic formula showed a trend towards higher faecal SIgA levels compared with the standard formula-fed infants reaching statistical significance at the age of 16 wk. In contrast, infants fed on the probiotic formula showed a highly variable faecal SIgA concentration with no statistically significant differences compared with the standard formula group. Formula-fed infants may benefit from infant formulas containing a prebiotic mixture of GOS and FOS because of the observed clear tendency to increase faecal SIgA secretion. Adding viable B. animalis strain Bb-12 to infant formula did not reveal any sign for such a trend.

UI MeSH Term Description Entries
D007071 Immunoglobulin A, Secretory The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS). Colostral IgA,IgA, Exocrine,IgA, Secretory,SIgA,Secretory IgA,Secretory Immunoglobulin A,Exocrine IgA,IgA, Colostral
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001942 Breast Feeding The nursing of an infant at the breast. Breast Fed,Breastfed,Milk Sharing,Wet Nursing,Breast Feeding, Exclusive,Breastfeeding,Breastfeeding, Exclusive,Exclusive Breast Feeding,Exclusive Breastfeeding,Sharing, Milk
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
September 1981, Acta paediatrica Scandinavica,
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
April 1985, The Journal of pediatrics,
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
November 1994, Journal of pediatric gastroenterology and nutrition,
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
November 1992, Journal of pediatric gastroenterology and nutrition,
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
October 1985, American journal of diseases of children (1960),
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
February 2001, Journal of pediatric gastroenterology and nutrition,
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
February 1983, The New England journal of medicine,
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
December 1989, Pediatrics,
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
May 1996, Acta paediatrica (Oslo, Norway : 1992),
A M Bakker-Zierikzee, and E A F Tol, and H Kroes, and M S Alles, and F J Kok, and J G Bindels
February 2010, European journal of nutrition,
Copied contents to your clipboard!